Penn researchers have developed a platform that emulates human bone marrow’s native environment. This breakthrough addresses a critical need in medical science, as animal studies often fail to fully ...

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing ...

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

Bone marrow is made of several main ingredients. These include hematopoietic stem cells (HSCs), which differentiate into the many types of cells in human blood; endothelial cells, which make up the ...